BPMC
Blueprint Medicines Corp
Price:  
117.78 
USD
Volume:  
610,072.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

BPMC WACC - Weighted Average Cost of Capital

The WACC of Blueprint Medicines Corp (BPMC) is 7.9%.

The Cost of Equity of Blueprint Medicines Corp (BPMC) is 8.00%.
The Cost of Debt of Blueprint Medicines Corp (BPMC) is 7.00%.

Range Selected
Cost of equity 6.60% - 9.40% 8.00%
Tax rate 0.30% - 0.40% 0.35%
Cost of debt 7.00% - 7.00% 7.00%
WACC 6.6% - 9.3% 7.9%
WACC

BPMC WACC calculation

Category Low High
Long-term bond rate 3.9% 4.4%
Equity market risk premium 4.6% 5.6%
Adjusted beta 0.59 0.8
Additional risk adjustments 0.0% 0.5%
Cost of equity 6.60% 9.40%
Tax rate 0.30% 0.40%
Debt/Equity ratio 0.03 0.03
Cost of debt 7.00% 7.00%
After-tax WACC 6.6% 9.3%
Selected WACC 7.9%